PolyPid Ltd
PYPD
View Detailed Chart
4.520USD
+0.170+3.91%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
75.19MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+3.91%
5 Days
-1.31%
1 Month
-1.09%
6 Months
+38.65%
Year to Date
+4.15%
1 Year
+55.86%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
PolyPid Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
PolyPid Ltd Info
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
Ticker SymbolPYPD
CompanyPolyPid Ltd
CEOAkselbrad (Dikla Czaczkes)
Websitehttps://www.polypid.com
Related Instruments
+3.66%
+3.14%
+0.93%
+2.01%
+1.82%
+1.60%
-0.95%
+4.49%
+2.10%
+9.92%
+2.76%
+4.15%
+1.79%
+4.17%
+0.72%
+1.10%
+2.46%
0.00%
+0.51%
+0.54%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
70203.940
+233.810 (+0.33%)
282.580
+22.390 (+8.61%)
2082.660
+30.930 (+1.51%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
